163.47USD-2.64%Mkt Cap: 27.28B USDP/E: 20.33Last update: 2026-05-26
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …
Industry Peers
Diagnostics & Research166.94BUSDP/E 24.7
122.72BUSDP/E 33.6
44.05BUSDP/E 41.1
34.33BCHFP/E 37.8
33.46BUSDP/E 43.3
32.69BUSDP/E 25.5
28.46BUSD—
22.36BUSDP/E 26.0
Indicators:|
Key Statistics
Company
Market Cap27.28B USD
Enterprise Value42.28B USD
Revenue (TTM)16.63B USD
Gross Profit5.43B USD
Net Income (TTM)1.36B USD
Revenue/Share97.79 USD
Last Price163.47 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees93.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS46266C1053
Valuation
P/E (Trailing)20.33
P/E (Forward)11.84
PEG0.70
EV/EBITDA14.09
EV/Revenue2.54
P/S1.69
P/B4.38
EPS (TTM)8.05
EPS (Forward)14.19
52W Range
134.6526% of range247.05
52W High247.05 USD
52W Low134.65 USD
Profitability
Gross Margin33.29%
Oper. Margin13.61%
EBITDA Margin18.04%
Profit Margin8.34%
ROE20.91%
ROA4.54%
Growth
Revenue Growth8.40%
Earnings Growth15.00%
Cash Flow & Leverage
Operating CF2.65B USD
CapEx (TTM)603.00M USD
FCF Margin12.97%
FCF Yield7.90%
Net Debt14.11B USD
Net Debt/EBITDA4.70
Balance Sheet
Debt/Equity2.45
Current Ratio0.75
Quick Ratio0.66
Book Value/Sh38.34 USD
Cash/Share12.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)228.60 USD
Target Range195.00 USD – 287.00 USD
# Analysts20
Ownership
Shares Out.166.90M
Float158.55M
Insiders1.08%
Institutions102.51%
Short Interest
Short Ratio3.5d
Short % Float3.44%
Short % Out.2.97%
Shares Short4.96M
Short (prev mo.)4.51M
Technical
SMA 50169.25 (-3.4%)
SMA 200196.14 (-16.7%)
Beta1.18
S&P 52W Chg28.31%
Avg Vol (30d)1.69M
Avg Vol (10d)1.59M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—